Showing 6,792 results

Filters Content type: News, Editors' picks Country: United States
Pharmaceutical industry

Trump Administration Caves To Pharma On Medicare Part D 'Protected Classes' Reform

Editor's pick
Forbes
17 May 2019
PrEP programmes & uptake

Being black and gay: how intersectional stigma impacts on the uptake of PrEP

News
17 May 2019
Pharmaceutical industry

A Leading HIV Drug Is Way Overpriced in the U.S.

Editor's pick
Bloomberg
17 May 2019
Pharmaceutical industry

Alexandria Ocasio-Cortez Tells Gilead CEO That ‘People Are Dying’ Because His Company Charges Nearly $2,000 For Drug That Sells For $8 In Australia

Editor's pick
Newsweek
17 May 2019
Money

Rapid rehousing support for homeless people living with HIV improves housing and HIV outcomes

News
17 May 2019
Transgender people

US: Rates of viral suppression similar between transgender women, cisgender patients

Editor's pick
Healio
16 May 2019
History of HIV & AIDS

A mystery illness killed a boy in 1969. Years later, doctors learned what it was: AIDS

Editor's pick
New Zealand Herald
16 May 2019
Bone & joint problems

US study suggests that ageing people with HIV may have an increased risk of arthritis

News
16 May 2019
Pharmaceutical industry

Gilead tries—and fails—to dodge lawsuit claiming it delayed safer HIV meds

Editor's pick
Fierce Pharma
15 May 2019
Clinical trials

UCSD has not told women with HIV of data breach, despite researchers' pleas

Editor's pick
inewsource
15 May 2019
Pharmaceutical industry

Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says

Editor's pick
STAT
15 May 2019
PrEP policies & guidelines

Statement on Gilead’s Announcement of PrEP Donation

Editor's pick
AVAC
14 May 2019
PrEP programmes & uptake

A Million Americans Need This Drug. Trump’s Deal Won’t Help Enough of Them.

Editor's pick
The New York Times (editorial)
14 May 2019
Clinical trials

Despite Uptick, Black and Latinx People Have Relatively Low Participation in HIV Vaccine Trials

Editor's pick
The Body Pro
14 May 2019
Pharmaceutical industry

Generics price-fixing lawsuit focuses on Teva's role as catalyst

Editor's pick
Bio Pharma Dive
14 May 2019
History of HIV & AIDS

Robert Rayford Died of HIV 50 Years Ago: We Are Still Failing Queer Youth of Color

Editor's pick
Newsweek
13 May 2019
PrEP policies & guidelines

Five Reasons the Gilead Giveaway is a Steaming Pile of Truvada

Editor's pick
My Fabulous Disease
12 May 2019
Alcohol

Increasing Alcohol Consumption Linked to Worsening HIV Severity

Editor's pick
Medscape (requires free registration)
12 May 2019
Ethnic & cultural minorities

Black women in the USA continue to be disproportionately affected by HIV, but there’s evidence that the gap may be slowly starting to close

Editor's pick
AVERT
10 May 2019
Discrimination & the law

US: HHS Rule Allows Religious Discrimination in Health Care

Editor's pick
Pride Source
10 May 2019
Retention & linkage to care

Cash Incentives, Peer Support May Not Incentivize HCV Treatment

Editor's pick
MD Magazine
10 May 2019
Pharmaceutical industry

Gilead Will Donate Truvada to U.S. for H.I.V. Prevention

Editor's pick
The New York Times
10 May 2019
PrEP programmes & uptake

Generic HIV prevention drug coming in 2020, Gilead says

Editor's pick
CNBC
9 May 2019
PrEP programmes & uptake

Official Statement responding to Gilead Sciences’ announcement that it will allow Teva to Manufacture a Generic Version of Truvada

Editor's pick
Breakthepatent.org
9 May 2019